A case of camrelizumab-induced anaphylaxis and successful rechallenge: a case report and literature review
{{output}}
Immune checkpoint inhibitors have been extensively utilized in the treatment of various malignancies, with camrelizumab being one of the agents in this therapeutic class. In this study, we report for the first time a case of an allergic reaction to camrelizuma... ...
